Home › Stocks › CATX

Perspective Therapeutics, Inc. (CATX): insider buying, hedge funds & Congress trades

Perspective Therapeutics, Inc. (CATX): 11 insider purchases in the last two years (2 opportunistic).

Insider buying

FiledInsiderSharesPriceValueType
Nov 17, 2025Hunt Jonathan Robert
Officer
11,000$2.03$22.3Kopportunistic
Nov 14, 2025Williamson Robert F III
Director
9,498$2.10$19.9Kno history
Apr 1, 2025Woods Lori A
Director
23,475$2.13$50.0Kopportunistic
Apr 1, 2025Graham Juan
Officer
33,333$2.25$75.0Kno history
Apr 1, 2025Williamson Robert F III
Director
60,337$2.19$132.0Kno history
Apr 1, 2025Spoor Johan M.
Director, Officer
26,676$2.23$59.6Kno history
Dec 6, 2024Henson Heidi
Director
25,975$3.85$100.0Kno history
Dec 4, 2024Spoor Johan M.
Director, Officer
8,000$3.77$30.2Kno history
Nov 27, 2024Hunt Jonathan Robert
Officer
12,829$3.82$49.0Kno history
Nov 27, 2024Williamson Robert F III
Director
6,266$3.64$22.8Kno history
Nov 26, 2024Spoor Johan M.
Director, Officer
26,500$3.79$100.4Kno history

Open-market purchases from SEC Form 4. "Opportunistic" = this insider trades every year but not on a fixed schedule (Cohen, Malloy & Pomorski); "routine" buys carry little information.

Get alerts for CATX

Free account. Know when insiders, famous funds or Congress trade it.

Start free